Structural Insights into the Mechanism of Carbapenemase Activity of the OXA-48 β-Lactamase.

Antimicrob Agents Chemother

Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA

Published: October 2019

Carbapenem-hydrolyzing class D carbapenemases (CHDLs) are enzymes that produce resistance to the last-resort carbapenem antibiotics, severely compromising the available therapeutic options for the treatment of life-threatening infections. A broad variety of CHDLs, including OXA-23, OXA-24/40, and OXA-58, circulate in , while the OXA-48 CHDL is predominant in Extensive structural studies of enzymes have provided important information regarding their interactions with carbapenems and significantly contributed to the understanding of the mechanism of their carbapenemase activity. However, the interactions between carbapenems and OXA-48 have not yet been elucidated. We determined the X-ray crystal structures of the acyl-enzyme complexes of OXA-48 with four carbapenems, imipenem, meropenem, ertapenem, and doripenem, and compared them with those of known carbapenem complexes of CHDLs. In the enzymes, acylation by carbapenems triggers significant displacement of one of two conserved hydrophobic surface residues, resulting in the formation of a channel for entry of the deacylating water into the active site. We show that such a channel preexists in apo-OXA-48 and that only minor displacement of the conserved hydrophobic surface residues occurs upon the formation of OXA-48 acyl-enzyme intermediates. We also demonstrate that the extensive hydrophobic interactions that occur between a conserved hydrophobic bridge of the CHDLs and the carbapenem tails are lost in OXA-48 in the absence of an equivalent bridge structure. These data highlight significant differences between the interactions of carbapenems with OXA-48 and those with enzymes and provide important insights into the mechanism of carbapenemase activity of the major CHDL, OXA-48.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761500PMC
http://dx.doi.org/10.1128/AAC.01202-19DOI Listing

Publication Analysis

Top Keywords

mechanism carbapenemase
12
carbapenemase activity
12
interactions carbapenems
12
conserved hydrophobic
12
insights mechanism
8
oxa-48
8
chdls enzymes
8
carbapenems oxa-48
8
displacement conserved
8
hydrophobic surface
8

Similar Publications

Purpose: is an important pathogenic bacterium in causing urinary tract infection. With the overuse of antibiotics, bacteria resistant to quinolones combined with carbapenems are increasing. In this study, we investigated the epidemiology, molecular characteristics, drug resistance of multidrug-resistant () isolated from urine samples.

View Article and Find Full Text PDF

Emerging Threats: Antimicrobial Resistance in Extended-Spectrum Beta-Lactamase and Carbapenem-Resistant Escherichia coli.

Microb Pathog

January 2025

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia. Electronic address:

Antimicrobial resistance (AMR) in Escherichia coli strains, particularly those producing Extended-Spectrum Beta-Lactamase (ESBL) and Carbapenemase (CR-Ec), represents a serious global health threat. These resistant strains have been associated with increased morbidity, mortality, and healthcare costs, as they limit the effectiveness of standard antibiotic therapies. The prevalence of ESBL- and CR-Ec-producing strains continues to rise, driven by the overuse and misuse of antibiotics in healthcare and agricultural settings, and facilitated by global interconnectedness through international travel, trade, and food distribution.

View Article and Find Full Text PDF

Rapid emergence, transmission, and evolution of KPC and NDM coproducing carbapenem-resistant Klebsiella pneumoniae.

Microbiol Res

January 2025

Research Institute of General Surgery, Jinling Hospital, the Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Electronic address:

Article Synopsis
  • Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a major clinical concern due to limited treatment options, worsened by the emergence of KPC and NDM co-producing strains.
  • A study identified 15 strains involved in an outbreak affecting 10 patients between October 2020 and May 2021, characterized by a highly stable hybrid plasmid co-harboring resistance genes.
  • Global genomic analysis of 327 KPC-NDM-CRKP genomes revealed potential transmission events during the COVID-19 period, highlighting the urgent public health threat posed by these resistant strains.
View Article and Find Full Text PDF

: Monomicrobial necrotizing fasciitis is associated with exceedingly high mortality rates. Although effective antimicrobial therapy is an important part of treatment, the traditional microbiological diagnostic methods are not fast enough to meaningfully influence early therapeutic decisions. : Here, we report the application of the BioMérieux Biofire Filmarray Joint Infection Panel (BFJIP) for the rapid detection of the causative agent and susceptibility prediction in such a case.

View Article and Find Full Text PDF

Background: The emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae (CRKP) is a significant public health concern, as colistin has been the last resort for treating such infections. This study aimed to investigate the prevalence and molecular characteristics of colistin-resistant CRKP isolates in Central South China.

Methods: CRKP isolates from twelve hospitals in Central South China were screened for colistin resistance using broth microdilution.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!